Clinical applications of laser scanning cytometry

被引:90
作者
Tárnok, A
Gerstner, AOH
机构
[1] Univ Leipzig, Dept Pediat Cardiol, Cardiac Ctr, D-04289 Leipzig, Germany
[2] Univ Leipzig, Dept Otorhinolaryngol Plast Surg, D-04289 Leipzig, Germany
来源
CYTOMETRY | 2002年 / 50卷 / 03期
关键词
fluorescence; cancer; leukemia; DNA; apoptosis; immunophenotyping; fine needle aspirate biopsies; tissue sections; histopathology; mitochondria; multiparametric analysis; slide-based cytometry; rare event detection; minimal sample volume;
D O I
10.1002/cyto.10099
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This study reviews existing and potential clinical applications of laser scanning cytometry (LSC) and outlines possible future developments. LSC provides a technology for solid phase cytometry. Fluorochrome-labeled specimens are immobilized on microscopic slides that are placed on a conventional epifluorescence microscope and analyzed by one or two lasers. Data comparable to flow cytometry are generated. In addition, the position of each event is recorded, a feature that allows relocalization and visualization of each measured event. The major advantage of LSC compared with other cytometric methods is the combination of two features: (a) the minimal clinical sample volume needed and (b) the connection of fluorescence data and morphological information for the measured event. Since the introduction of LSC, numerous methods have been established for the analysis of cells, cellular compartments, and tissues. Although most cytometric methods use only two or three colors, the characterization of specimens with up to five fluorochromes is possible. Most clinical applications have been designed to determine ploidy and immunophenotype; other applications include analyses of tissue biopsies and sections, fluorescence in situ hybridization, and the combination of vital and nonvital information on a single-cell basis. With the currently available assays, LSC has proven its wide spectrum of clinical applicability in slide-based cytometry and can be introduced as a standard technology in multiple clinical settings. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:133 / 143
页数:11
相关论文
共 127 条
[1]  
Abdel-Moneim I, 2000, ANAL QUANT CYTOL, V22, P393
[2]  
[Anonymous], 1859, CELLULARPATHOLOGIE
[3]  
Bacso Z, 2001, CYTOMETRY, V45, P180, DOI 10.1002/1097-0320(20011101)45:3<180::AID-CYTO1161>3.0.CO
[4]  
2-V
[5]  
Bacsó Z, 2000, CANCER RES, V60, P4623
[6]  
Bajaj S, 2000, CYTOMETRY, V39, P285
[7]  
Baumgartner A, 2001, CYTOMETRY, V44, P156, DOI 10.1002/1097-0320(20010601)44:2<156::AID-CYTO1096>3.3.CO
[8]  
2-X
[9]  
Bedner E, 1997, CYTOMETRY, V29, P191, DOI 10.1002/(SICI)1097-0320(19971101)29:3<191::AID-CYTO1>3.0.CO
[10]  
2-F